| abstract |
The present invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent c-fms kinase inhibitors. The present invention relates to novel compounds of formula (I), or solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof:n n n n n n n n Wheren n n W, A, Y, Z, R 101 and R 200 are as defined in the specification. |